Related Experiment Videos

Divergent response to LPS and bacteria in CD14-deficient murine macrophages

K J Moore1, L P Andersson, R R Ingalls

  • 1Lipid Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Insights

Mice lacking the CD14 protein show no inflammatory response to lipopolysaccharide (LPS). However, they still release inflammatory mediators when exposed to whole bacteria, indicating alternative immune pathways exist.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Gram-negative bacteria and lipopolysaccharide (LPS) trigger inflammatory responses linked to septic shock.
  • The CD14 membrane protein initiates LPS-induced inflammatory signaling.

Purpose of the Study:

  • To generate and characterize CD14-null mice to investigate the role of CD14 in inflammatory responses.
  • To understand the compensatory mechanisms in the absence of CD14.

Main Methods:

  • Generation of CD14-null mice by deleting the entire CD14 coding region.
  • Assessing TNF-alpha and IL-6 production in macrophages via LPS and whole Escherichia coli stimulation.
  • Utilizing FACS analysis for bacterial binding and uptake, and receptor blockade (neutrophil inhibitory factor) and phagocytosis inhibition (cytochalasin B).

Main Results:

  • CD14-null macrophages failed to produce TNF-alpha and IL-6 in response to LPS, with impaired NF-kappaB and c-Jun N-terminal kinase pathway activation.
  • Bacterial binding and uptake were unaffected in CD14-null macrophages.
  • Whole E. coli stimulated TNF-alpha release in CD14-null macrophages, an effect partially mediated by CD11b/CD18 and dependent on phagocytosis.

Conclusions:

  • CD14 is crucial for macrophage response to free LPS.
  • Receptors like CD11b/CD18 can compensate for CD14's absence in response to whole bacteria.
  • Phagocytosis plays a role in CD14-independent inflammatory responses to bacteria.

Related Concept Videos